 To obtain additional safety data in subjects who have previously completed the MBP8298-01 study A Double Blind Placebo Controlled Multi-Centre to Evaluate the Efficacy and Safety of MBP8298 in Subjects with Secondary Multiple Sclerosis Dirucotide is generic name for MBP8298. 